Page last updated: 2024-12-10

raphanusamic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

raphanusamic acid: RN given for (R)-isomer; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

raphanusamic acid : A thiazolidinemonocarboxylic acid that is 2-thioxo-1,3-thiazolidine with the carboxy group located at position 4 (the R-enantiomer). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID3035791
CHEBI ID136957
SCHEMBL ID1149837
MeSH IDM0300868

Synonyms (21)

Synonym
(4r)-(-)-2-thioxo-4-thiazolidinecarboxylic acid, 99%
raphanusamic acid
(r)-(-)-2-thioxo-4-thiazolidinecarboxylic acid
(4r)-2-thioxo-4-thiazolidinecarboxylic acid
CHEBI:136957
(4r)-2-sulfanylidene-1,3-thiazolidine-4-carboxylic acid
98169-56-3
(4r)-5-carboxythiazolidine-2-thione
(4r)-2-thioxo-1,3-thiazolidine-4-carboxylic acid
AKOS015893999
(4r)-(-)-2-thioxo-4-thiazolidinecarboxylic acid
SCHEMBL1149837
(r)thiazolidine-2-thione-4-carboxylic acid
TS-00120
(4r)-2-sulfanyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid
DTXSID00243495
(r)-2-thioxothiazolidine-4-carboxylic acid
(4r)-()-2-thioxo-4-thiazolidinecarboxylic acid
(4r)-(-)-2-thioxothiazolidine-4-carboxylic acid
A916396
(r)-2-thioxothiazolidine-4-carboxylicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
Arabidopsis thaliana metaboliteAny plant metabolite that is produced by Arabidopsis thaliana.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
thiazolidinemonocarboxylic acidA thiazolidine or thiazolidine derivative carrying a single carboxy substituent.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.21 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]